News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

April

21

electroCore Announces Publication of Investigator-Initiated Trial Data for SAVIOR-1 in COVID-19 Patients in Frontiers in Neurology

Evaluation results indicate nVNS therapy may potentially improve the course of patients’ COVID-19 symptoms...

29

electroCore Announces Open Access and Submission of Manuscript from SAVIOR-1

Study evaluated impact of non-invasive vagus nerve stimulation in hospitalized COVID-19 patients ROCKAWAY, NJ, Sept....

8

electroCore Announces Top Line Results from SAVIOR-1 Study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients

nVNS Decreases Certain Biomarkers Associated with the Severity of COVID-19 through Five Days of...

24

Non-Invasive Vagus Nerve Stimulation (nVNS) Enters New Stage of COVID-19 Research

electroCore and the Hospital Clínico Universitario de Valencia have completed patient enrollment in SAVIOR-1 study ROCKAWAY,...

Recent developments

News

April

21

electroCore Announces Publication of Investigator-Initiated Trial Data for SAVIOR-1 in COVID-19 Patients in Frontiers in Neurology

September

29

electroCore Announces Open Access and Submission of Manuscript from SAVIOR-1

April

8

electroCore Announces Top Line Results from SAVIOR-1 Study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients

February

24

Non-Invasive Vagus Nerve Stimulation (nVNS) Enters New Stage of COVID-19 Research